Other Policy Priorities
Alzheimer’s Breakthrough Act
Over the next 40 years, caring for individuals with Alzheimer’s will cost American society $20 trillion – including $15 trillion to Medicare and Medicaid.
Scientists believe we are at the tipping point on Alzheimer’s research. We have the ideas, the technology, and the will. But we do not have a commitment from the federal government.
The Alzheimer’s Breakthrough Act (H.R. 1897) would ensure an appropriate commitment to Alzheimer’s research. Specifically, the bill would:
- Make Alzheimer’s research a priority at the National Institutes of Health (NIH)
- Create public-private partnerships to develop treatments and a cure
- Require the leadership at NIH to provide the funding necessary to get the job done, or explain to Congress why they are not
Learn more about the Alzheimer’s Breakthrough Act
HOPE for Alzheimer’s Act
An early and documented diagnosis and access to care planning services leads to better outcomes for individuals with Alzheimer’s and their caregivers. However, as many as half of the estimated 5.4 million Americans with Alzheimer’s have never received a formal diagnosis.
The Health Outcomes, Planning, and Education (HOPE) for Alzheimer’s Act (S. 738 / H.R. 1386) would:
- Provide Medicare coverage for a package of services including clinical diagnosis of Alzheimer’s disease and care planning
- Require documentation of the diagnostic evaluation and any care planning provided in an individuals’ primary medical record
